Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries.
Saved in:
| Title: | Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. |
|---|---|
| Authors: | Smith DJ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.; COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta, GA, United States., Bi H; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Hamman J; Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Ma X; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States., Mitchell C; Health and Environmental Sciences Institute, Washington, DC, United States., Nyirenda K; Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi., Monera-Penduka T; Research Unit for Safety of Herbs and Drugs, University of Zimbabwe, Harare, Zimbabwe., Oketch-Rabah H; United States Pharmacopeia, Rockville, MD, United States., Paine MF; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States., Pettit S; Health and Environmental Sciences Institute, Washington, DC, United States., Pheiffer W; DSI/NWU Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Van Breemen RB; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States., Embry M; Health and Environmental Sciences Institute, Washington, DC, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2023 Jul 12; Vol. 14, pp. 1210579. Date of Electronic Publication: 2023 Jul 12 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37502215 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smith+DJ%22">Smith DJ</searchLink>; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.; COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Bi+H%22">Bi H</searchLink>; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Hamman+J%22">Hamman J</searchLink>; Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Mitchell+C%22">Mitchell C</searchLink>; Health and Environmental Sciences Institute, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Nyirenda+K%22">Nyirenda K</searchLink>; Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi.<br /><searchLink fieldCode="AU" term="%22Monera-Penduka+T%22">Monera-Penduka T</searchLink>; Research Unit for Safety of Herbs and Drugs, University of Zimbabwe, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Oketch-Rabah+H%22">Oketch-Rabah H</searchLink>; United States Pharmacopeia, Rockville, MD, United States.<br /><searchLink fieldCode="AU" term="%22Paine+MF%22">Paine MF</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States.<br /><searchLink fieldCode="AU" term="%22Pettit+S%22">Pettit S</searchLink>; Health and Environmental Sciences Institute, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Pheiffer+W%22">Pheiffer W</searchLink>; DSI/NWU Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.<br /><searchLink fieldCode="AU" term="%22Van+Breemen+RB%22">Van Breemen RB</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States.<br /><searchLink fieldCode="AU" term="%22Embry+M%22">Embry M</searchLink>; Health and Environmental Sciences Institute, Washington, DC, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2023 Jul 12; Vol. 14, pp. 1210579. <i>Date of Electronic Publication: </i>2023 Jul 12 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37502215 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2023.1210579 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1210579 Titles: – TitleFull: Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smith DJ – PersonEntity: Name: NameFull: Bi H – PersonEntity: Name: NameFull: Hamman J – PersonEntity: Name: NameFull: Ma X – PersonEntity: Name: NameFull: Mitchell C – PersonEntity: Name: NameFull: Nyirenda K – PersonEntity: Name: NameFull: Monera-Penduka T – PersonEntity: Name: NameFull: Oketch-Rabah H – PersonEntity: Name: NameFull: Paine MF – PersonEntity: Name: NameFull: Pettit S – PersonEntity: Name: NameFull: Pheiffer W – PersonEntity: Name: NameFull: Van Breemen RB – PersonEntity: Name: NameFull: Embry M IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 07 Text: 2023 Jul 12 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
